Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

WHO recently launched new guidance on Opioid agonist maintenance treatment as an essential health service: implementation ...

Other hospitals across the country have modeled their own youth opioid treatment programs after the one at Valley Medical ...

Medetomidine, a veterinary sedative, mixed into fentanyl has sent thousands to hospitals, not only for overdose but for ...

Prison officials are trying to reduce the risk of overdose by providing medications for opioid use disorder before release.

More than half the people in jail or prison in the U.S. have been diagnosed with substance use disorder (SUD). By law, ...

Most people think addiction means a person has severe withdrawal when not taking alcohol or drugs. But withdrawal symptoms ...

Tennessee will receive more than $1.2 billion in opioid settlement funds. Experts fear the money isn’t reaching people who ...

A new study shows Black Medicaid patients with opioid use disorder face delays and barriers to methadone and other treatments.

BioCorRx Inc. (OTCQB:BICX), based in Anaheim, CA, focused on improving the wellness of those struggling with alcohol, opioid, and other addictive disorders, today announced that Lourdes Felix, CEO, ...